Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope

Tsung-Che Chang, Yoshiyuki Manabe,* Keita Ito, Ryuku Yamamoto, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani,* Yukari Fujimoto, Chun-Cheng Lin, and Koichi Fukase*

RSC Adv. 2022, 12, 18985–18993. DOI: 10.1039/D2RA03286D.